Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

A new method accurately measures nine specific hormones in human blood.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Minoxidil can reduce functions related to androgen receptors.

Testosterone may influence COVID-19 severity and outcomes.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Targeting the Smoothened receptor shows promise for treating certain cancers.